Why Your Hormones Feel Off (Even When Your Labs Are “Normal”)
Many patients seeking care for hormone-related symptoms have already had lab testing completed.
They are often told that everything is “normal.”
And yet, symptoms persist.
This disconnect highlights an important limitation in how hormone health is commonly evaluated.
Hormones are dynamic, not static
Hormones are not fixed values.
They fluctuate continuously in response to internal and external signals.
In women, estrogen and progesterone shift significantly across the menstrual cycle.
Cortisol follows a diurnal rhythm, peaking in the morning and declining throughout the day.
Insulin responds to food intake and metabolic demand.
Thyroid hormones are influenced by stress, inflammation, nutrient status, and overall metabolic health.
Because of this, a single lab value represents only a moment in time.
It does not capture the broader patterns that often explain symptoms.
The importance of timing
Hormone testing is highly dependent on timing.
For example:
- Estrogen and progesterone vary significantly depending on the phase of the menstrual cycle
- Testing progesterone too early or too late in the luteal phase can give misleading results
- It is considered best practice to measure testosterone in the morning, between 7am-10am
- Cortisol levels fluctuate throughout the day and require multiple measurements to assess patterns
- Thyroid labs can also fluctuate in a way that follows estrogen patterns, and timing of lab draws also matters depending on if you’re taking thyroid medication, and which kind.
Without proper timing, even accurate lab tests can be misinterpreted.
This is one of the reasons patients are often told their hormones are “normal” when their clinical picture suggests otherwise.
Reference ranges vs optimal function
Most laboratory reference ranges are designed to identify disease.
They are not designed to identify early imbalance or suboptimal function.
Reference ranges are typically based on population averages, which include individuals who may already have underlying dysfunction.
Many, though not all, laboratory reference ranges are historically based on data from white, male populations, often neglecting demographic diversity. While many tests are now sex-specific (split by male/female), they frequently lack consideration for race, ethnicity, or age, potentially leading to diagnostic inaccuracies for broader populations.
As a result, “normal” does not always mean optimal.
Patients may fall within a reference range and still experience:
- Fatigue
- Mood changes
- PMS
- Irregular cycles
- Sleep disturbances
Research published in Endocrine Reviews highlights the complexity of hormone signaling and the limitations of single-measure assessments in fully capturing endocrine function.1
Hormone relationships matter more than isolated values
Hormones do not act independently.
They function as part of an interconnected system. I always talk to patients about how they “dance” together.
For example:
- The balance between estrogen and progesterone plays a critical role in menstrual cycle regulation and symptom expression
- Cortisol influences blood sugar regulation and can impact sex hormone production
- Thyroid function is closely tied to stress, (i.e. cortisol), nutrient status, and inflammation
It is possible for individual hormone levels to fall within normal ranges while their relationships to one another are imbalanced.
This is often where symptoms originate.
Hormone metabolism and clearance
Hormone health is not only about production.
It is also about how hormones are metabolized and cleared from the body.
The liver plays a central role in hormone metabolism, particularly estrogen.
After being processed, hormones are excreted through the gastrointestinal tract.
If detoxification or elimination pathways are impaired, hormones may be recirculated and can “build up” in the system.
This can contribute to symptoms such as:
- PMS
- Breast tenderness
- Bloating
- Mood changes
- Fibroids
- Heavy periods
- Growths – both benign and malignant
Research has shown that alterations in estrogen metabolism pathways can influence long-term health outcomes, including cancer risk.
The role of the gut (the estrobolome)
The gut microbiome plays a key role in hormone regulation.
Specific bacterial populations, collectively referred to as the estrobolome, influence how estrogen is metabolized and reabsorbed.
Disruptions in gut health may contribute to:
- Increased estrogen recirculation
- Inflammation
- Hormonal imbalance
This highlights the importance of considering gut health when evaluating hormone-related symptoms.
Why symptoms matter
Symptoms are not separate from physiology.
They are an expression of how systems are functioning.
Ignoring symptoms because labs are “normal” can delay appropriate intervention. The numbers on the paper can tell us a lot, but they mean much less than how you actually feel.
Clinical practice consistently shows that symptom patterns provide critical insight into underlying imbalance, even when standard lab markers do not.
We also know that patients know their bodies best. Trust your intuition and keep fighting for a provider that hears you.
Moving toward a more functional approach
A functional and naturopathic approach to hormone health considers:
- Hormone production
- Hormone signaling
- Hormone metabolism
- Hormone clearance
- The hormone “dance”
- AND…QUALITY OF LIFE
This allows for a more complete understanding of what may be contributing to symptoms.
In some cases, more comprehensive testing methods, such as dried urine hormone testing, can provide additional insight into hormone patterns and metabolism.
Final thoughts
Hormone health is complex and highly individualized.
A single lab value rarely tells the full story.
When symptoms persist despite “normal” labs, it is often an indication that a deeper, more pattern-based approach is needed.
Understanding hormone health requires looking beyond isolated numbers and considering how the system is functioning as a whole.
References
- Gore AC, et al. Endocrine Reviews. 2015;36(6):E1–E150.https://doi.org/10.1210/er.2015-1010
- Handelsman DJ. Lancet Diabetes Endocrinol. 2017;5(6):443–455.https://doi.org/10.1016/S2213-8587(16)30325-1
- Baker JM, et al. Nat Rev Endocrinol. 2017;13(10):628–642.https://doi.org/10.1038/nrendo.2017.58
- Dallman MF, et al. Endocrine Reviews. 2004;25(4):534–560.https://doi.org/10.1210/er.2003-0032

